Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Dine Brands
DIN
$453M
| $8.75M | ﹤0.01% |
207,899
-9,709
| -4% | -$392K |
|
2177
Phibro Animal Health
PAHC
$1.46B
| $8.75M | ﹤0.01% |
332,990
-7,418
| -2% | -$184K |
|
2178
Univest Financial
UVSP
$1.22B
| $8.73M | ﹤0.01% |
540,830
+107,656
| +25% | +$1.73M |
|
2179
Nutrien
NTR
$32.1B
| $8.72M | ﹤0.01% |
271,755
-110,233
| -29% | -$3.84M |
|
|
GOOD
2180
Gladstone Commercial Corp
GOOD
$593M
| $8.72M | ﹤0.01% |
465,225
+2,380
| +0.5% | +$39K |
|
2181
Patterson-UTI
PTEN
$3.64B
| $8.71M | ﹤0.01% |
2,511,223
+793,487
| +46% | +$2.74M |
|
|
SWCH
2182
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $8.71M | ﹤0.01% |
488,990
+95,562
| +24% | +$1.67M |
|
2183
Vericel Corp
VCEL
$2.32B
| $8.71M | ﹤0.01% |
630,053
+41,567
| +7% | +$563K |
|
|
TARO
2184
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $8.69M | ﹤0.01% |
130,698
+69,439
| +113% | +$4.66M |
|
2185
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund
QLVD
$54.7M
| $8.67M | ﹤0.01% |
363,855
| – | – |
|
2186
Ethan Allen Interiors
ETD
$614M
| $8.67M | ﹤0.01% |
732,981
+95,139
| +15% | +$1.06M |
|
2187
Collegium Pharmaceutical
COLL
$1.16B
| $8.65M | ﹤0.01% |
494,451
+69,163
| +16% | +$1.35M |
|
2188
Columbia Financial
CLBK
$1.12B
| $8.64M | ﹤0.01% |
619,475
-15,721
| -2% | -$220K |
|
2189
FlexShares Credit-Scored US Long Corporate Bond Index Fund
LKOR
$30.3M
| $8.64M | ﹤0.01% |
193,211
+111,543
| +137% | +$6.62M |
|
|
SRDX
2190
DELISTED
Surmodics
SRDX
| $8.62M | ﹤0.01% |
199,387
+7,164
| +4% | +$271K |
|
|
OSG
2191
Octave Specialty Group
OSG
$256M
| $8.62M | ﹤0.01% |
601,665
-5,935
| -1% | -$86.7K |
|
2192
Cue Biopharma
CUE
$112M
| $8.61M | ﹤0.01% |
11,707
+3,825
| +49% | +$2.77M |
|
2193
Sibanye-Stillwater
SBSW
$7.02B
| $8.6M | ﹤0.01% |
993,740
-7,563
| -0.8% | -$57.6K |
|
|
BBT
2194
Beacon Financial Corp
BBT
$2.68B
| $8.59M | ﹤0.01% |
779,820
-26,140
| -3% | -$336K |
|
2195
Anterix
ATEX
$1.94B
| $8.57M | ﹤0.01% |
188,983
+36,931
| +24% | +$1.89M |
|
2196
DXP Enterprises
DXPE
$2.61B
| $8.57M | ﹤0.01% |
430,442
+227,144
| +112% | +$3.66M |
|
2197
Sierra Bancorp
BSRR
$528M
| $8.56M | ﹤0.01% |
453,402
-692
| -0.2% | -$12.5K |
|
2198
Vertiv
VRT
$107B
| $8.55M | ﹤0.01% |
+630,662
| New | +$7.35M |
|
2199
Hooker Furnishings Corp
HOFT
$159M
| $8.51M | ﹤0.01% |
437,610
+32,313
| +8% | +$517K |
|
2200
Oceaneering
OII
$4.78B
| $8.51M | ﹤0.01% |
1,332,128
+21,001
| +2% | +$111K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,280 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.